2018 FDLI Annual Conference
May 3, 2018

On May 3, Axinn partner Chad Landmon spoke at the Food and Drug Law Institute's Annual Conference in Washington, DC. The conference provided a forum to discuss the most current advances and forthcoming topics of interest in FDA law. Chad's presentation specifically focused on developments regarding biosimilars.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.